Similar to the results from ALT, Panax ginseng administration significantly reduced AST levels in NAFLD-induced animals (SMD: −2.86 IU/L; 95% CI: −3.70 to −2.02 mg/dL; p < 0.0001) (Figure 3B). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.